Search

everythinglearnresearchcommunity

for

Search:↓

More research is needed to understand hair and scalp disorders in people with skin of color.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Shift work disrupts the body's natural clock, leading to health problems.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Post-COVID-19 hair loss is not linked to vitamin D or quality of life but is linked to hair graying.

Copper deficiency is linked to post-COVID-19 hair loss in women.

Vitamin D supplements significantly improved post-COVID-19 symptoms in deficient patients.

A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.

About 61% of women who had COVID-19 experienced hair loss afterward.